SBC Medical Group Holdings Incorporated Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
SBC Medical Group Holdings Incorporated (SBC) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of $11.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $11.16M, a 357.50% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $11.33M, a 47.29% decline year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $14.28M, a 118.08% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $12.83M, a 352.76% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was $51.05M, a 9.33% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was $46.69M, a 21.08% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was $38.56M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.16M 10-Q · filed 2026-08-13 | $22.49M 10-Q · filed 2026-08-13 | $36.77M derived: sum of 3 quarters · filed 2026-08-13 | $49.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $11.33M 10-Q · filed 2026-08-13 | $25.61M derived: sum of 2 quarters · filed 2026-08-13 | $38.44M derived: sum of 3 quarters · filed 2026-08-13 | $40.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $14.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $27.11M derived: sum of 2 quarters · filed 2026-03-27 | $29.55M derived: sum of 3 quarters · filed 2026-08-13 | $51.05M 10-K · filed 2026-03-27 |
| 2025-09-30 | $12.83M 10-Q · filed 2025-11-14 | $15.27M derived: sum of 2 quarters · filed 2026-08-13 | $36.77M 10-Q · filed 2025-11-14 | $43.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $2.44M 10-Q · filed 2026-08-13 | $23.93M 10-Q · filed 2026-08-13 | $30.48M derived: sum of 3 quarters · filed 2026-08-13 | $33.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $21.49M 10-Q · filed 2026-08-13 | $28.04M derived: sum of 2 quarters · filed 2026-08-13 | $30.87M derived: sum of 3 quarters · filed 2026-08-13 | $49.43M derived: sum of 4 quarters · filed 2026-08-13 |
| 2024-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $9.38M derived: sum of 2 quarters · filed 2026-03-27 | $27.94M derived: sum of 3 quarters · filed 2026-03-27 | $46.69M 10-K · filed 2026-03-27 |
| 2024-09-30 | $2.83M 10-Q · filed 2025-11-14 | $21.39M derived: sum of 2 quarters · filed 2025-11-14 | $40.14M 10-Q · filed 2025-11-14 | $54.37M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $18.56M 10-Q · filed 2025-11-14 | $37.31M 10-Q · filed 2025-08-13 | $51.54M derived: sum of 3 quarters · filed 2025-11-14 | $59.59M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-03-31 | $18.75M 10-Q · filed 2025-11-14 | $32.98M derived: sum of 2 quarters · filed 2025-11-14 | $41.04M derived: sum of 3 quarters · filed 2025-11-14 | $50.89M derived: sum of 4 quarters · filed 2025-11-14 |
| 2023-12-31 | $14.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $22.29M derived: sum of 2 quarters · filed 2025-03-28 | $32.14M derived: sum of 3 quarters · filed 2025-03-28 | $38.56M 10-K · filed 2025-03-28 |
| 2023-09-30 | $8.06M 10-Q · filed 2024-11-13 | $17.91M derived: sum of 2 quarters · filed 2024-11-13 | $24.33M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $9.86M 10-Q · filed 2024-11-13 | $16.27M derived: sum of 2 quarters · filed 2024-11-13 | ||
| 2023-03-31 | $6.42M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |